Patent ID: 8586782
Filing Date: 2013-11-19
Classification: A61P,C07C

Abstract:
1. A method of treating rheumatoid arthritis, osteoarthritis, dysmenorrhea, pain or inflammation in mammals which comprises administering to a mammal in need thereof a correspondingly effective amount of a compound selected from the group consisting of 5-methyl-2-(2′,4′-dichloro-3′-methylanilino)phenylacetic acid; 5-Methyl-2-(2′,4′-dichloro-3′-methylanilino)phenylacetic acid diethylamine salt; sodium 5-Methyl-2-(2′,4′-dichloro-3′-methylanilino)phenylacetate; 5-Methyl-2-(2′,4′-dichloro-3′-methylanilino)phenylacetic acid tromethamine salt; calcium 5-Methyl-2-(2′,4′-dichloro-3′-methylanilino)phenylacetate monohydrate; Lysine 5-Methyl-2-(2′,4′-dichloro-3′-methylanilino)phenylacetate monohydrate; and choline 5-Methyl-2-(2′,4′-dichloro-3′-methylanilino)phenylacetate monohydrate.